Copertina

Data and Code Supporting: 'Prevalence of Chromosomal Abnormalities and Factors Associated with Prenatal Cell-Free DNA (cfDNA) Screening Success in Indonesia: A Retrospective Cross-Sectional Study'

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autori principali:	Adyasa, Zoya Marie, Putri, Nurhayati, Herlambang, Afri, Nedra, Wan, Pradipta, Ariel
Natura:	Recurso digital
Pubblicazione:	Zenodo 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Clinical Utility of Prenatal cfDNA Screening for Sex Chromosome Aneuploidies: A Single Center Experience
di: Ying Lin, et al.
Pubblicazione: (2026)

Prenatal Screening Via cfDNA – Paired‐End Sequencing Utilizing Fragment Size Information Reduces the Screen Positive Rate for X Chromosome Aneuploidies
di: Susan Hancock, et al.
Pubblicazione: (2026)

Detection of fetal cfDNA in maternal blood
di: Klaus Rieneck, et al.
Pubblicazione: (2025)

Correspondence on “Current Controversy in Prenatal Diagnosis: The Use of cfDNA to Screen for Monogenic Conditions in Low Risk Populations Is Ready for Clinical Use”
di: Julia Wynn, et al.
Pubblicazione: (2024)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
di: Marta Victoria Lorenzo‐Sánchez, et al.
Pubblicazione: (2025)

Persistent Uninterpretable or Failed Prenatal Cell‐Free DNA Screening Indicates a High‐Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA‐Analysis: A Prospective Cohort Study
di: L. Lannoo, et al.
Pubblicazione: (2025)

Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients
di: İrem Peker Eyüboğlu, et al.
Pubblicazione: (2024)

Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients
di: Yidan Ma, et al.
Pubblicazione: (2024)

From DNA Methylation Microarray to Digital PCR : A Stepwise Strategy for Tissue Specific cfDNA Biomarker Development
di: David H. Murray, et al.
Pubblicazione: (2026)

Interfacial cfDNA Enrichment and Amplification with On‐Chip Thermoplasmonics for Highly Sensitive Cancerous Liquid Biopsy
di: Danhua Wang, et al.
Pubblicazione: (2024)

Immediate Postoperative cfDNA Elevation Predicts Pain After Robot‐Assisted Radical Prostatectomy
di: Noritaka Ishii, et al.
Pubblicazione: (2025)

5‐Hydroxymethylcytosine Profiles of cfDNA in Urine as Diagnostic, Differential Diagnosis and Prognostic Markers for Multiple Myeloma
di: Weiwei Xie, et al.
Pubblicazione: (2024)

Evaluation of cfDNA fragmentation characteristics in plasma for the diagnosis of lung cancer: A prospective cohort study
di: Fudong Xu, et al.
Pubblicazione: (2024)

Donor‐Derived Cell‐Free DNA (dd‐cfDNA) as an Early Noninvasive Biomarker of Graft Injury in Pig‐to‐Monkey Islet Xenotransplantation
di: Ji‐Jing Yan, et al.
Pubblicazione: (2026)

Harnessing viral footprints in circulating free DNA ( cfDNA ) for early cancer detection: A focus on liquid‐biopsy‐based screening
di: Richard Donkor Amponsah, et al.
Pubblicazione: (2025)

Comparative Liquid Biopsy Testing for KRAS Mutations From Plasma Cell‐Free DNA ( cfDNA ) and Extracellular Vesicles in Lung Adenocarcinoma
di: Caeli J. Zahra, et al.
Pubblicazione: (2026)

LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA
di: Irena Abramovic, et al.
Pubblicazione: (2024)

The Efficacy of Liquid Biopsy of Total cfDNA for Predicting Systemic Metastasis in Japanese Patients With Oral Squamous Cell Carcinoma
di: Masahiro Uchibori, et al.
Pubblicazione: (2024)

EP17.37: Low fetal fraction of cfDNA and obstetric complications in screening centre Gennet 2019–2022
di: M. Holub, et al.
Pubblicazione: (2024)

Detection of neuron‐derived cfDNA in blood plasma: A novel screening and monitoring approach for Alzheimer's disease and other neurodegenerative conditions
di: Chad Pollard
Pubblicazione: (2025)

Performance of Prenatal Cell‐Free DNA Screening for Foetal Chromosome Aneuploidies and Microdeletion/Microduplication Syndromes: A Retrospective Study of 64,482 Consecutive Cases From a Prenatal Diagnosis Centre in China
di: Feiyan Pan, et al.
Pubblicazione: (2025)

Towards a People-Driven African Union: Current Obstacles and New Opportunities
di: AfriMAP
Pubblicazione: (2026)

Analytical and Clinical Validation of Solo‐Test Driver: A Targeted Amplicon‐Based NGS Test‐System for FFPE and cfDNA Analysis in Clinical Oncology Setting
di: Maxim Ivanov, et al.
Pubblicazione: (2025)

MUTE‐Seq: An Ultrasensitive Method for Detecting Low‐Frequency Mutations in cfDNA With Engineered Advanced‐Fidelity FnCas9 (Adv. Mater. 47/2025)
di: Sunghyeok Ye, et al.
Pubblicazione: (2025)

Nuchal Translucency Measurement in First Trimester Screening Ultrasound as a Marker of Abnormal Cell‐Free DNA on Non‐Invasive Prenatal Testing
Pubblicazione: (2025)

Public Perspectives Around Prenatal Screening of Chromosomal Abnormalities: A Focus Group Study Comparing Metropolitan and Rural/Regional Areas in Australia
di: Amber Salisbury, et al.
Pubblicazione: (2025)

Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes
di: Ivonne Bedei, et al.
Pubblicazione: (2025)

Can cell‐free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I−III a nonsmall cell lung cancer (NSCLC)? A pilot study
di: Jyoutishman Saikia, et al.
Pubblicazione: (2024)

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer
di: Anouchka Modesto, et al.
Pubblicazione: (2025)

Modern Organization Theory and Critical Organization Theory
di: Akdila Bulanov, Afri Wandi Zahri Ramadhan, Nabila Sukma, Putri Varisya
Pubblicazione: (2026)

Microkinetic Modelling of Electrochemical Oxygen Evolution Reaction on Ir(111)@N‐Graphene Surface
di: Adyasa Priyadarsini, et al.
Pubblicazione: (2025)

Chromosomal Microarray Analysis and Karyotype Analysis for Prenatal Diagnosis of Fetuses With Abnormal Ultrasound Soft Markers
di: Lina Liu, et al.
Pubblicazione: (2025)

Analysis of Prenatal Diagnosis and Pregnancy Decisions of 767 Singleton Pregnancies With Positive Prenatal Cell‐Free DNA Screening Results in Southwest China
di: Yun Chen, et al.
Pubblicazione: (2025)

DNA Mimic Foldamer Recognition of a Chromosomal Protein
di: Deepak Deepak, et al.
Pubblicazione: (2025)

Frequency and Distribution of Incidental Chromosomal Abnormalities Detected by Peripheral Blood Karyotyping: A Retrospective Study
di: Yaqin Zhang, et al.
Pubblicazione: (2026)

Unit Time/Cost Study of the Cataloging Unit, Technical Services Division, Tucson Public Library.
di: Kayner, Nedra L.
Pubblicazione: (1978)

Analyse et modélisation des paramètres d’exploitation des stocks du Bivalve Ruditapes decussatus des côtes Tunisiennes.
di: Zamouri-Langar, Nedra
Pubblicazione: (2010)

Chromosomal Structural Abnormality Diagnosis by Homologous Similarity
di: Li, Juren, et al.
Pubblicazione: (2024)

Improving the Performance of Prenatal Cell‐Free DNA Screening Through Size‐Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High‐Risk Pregnancies
di: Liang Hu, et al.
Pubblicazione: (2025)

Evaluating Chromosomal Mosaicism in Prenatal Diagnosis: The Complementary Roles of Chromosomal Microarray Analysis and Karyotyping
di: Chenxia Xu, et al.
Pubblicazione: (2025)